Claudia Peitzsch

9PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsRadiation therapyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 24, 2024
Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer.

Iñaki Schniewind, Maria José Besso, Sebastian Klicker

|Feb 03, 2023
Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy.

Daria Klusa, Fabian Lohaus, Andre Franken

|Jan 08, 2023
Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines.

Dinah Linke, Lukas Donix, Claudia Peitzsch

|Nov 05, 2019
Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse.

Michael Seifert, Claudia Peitzsch, Ielizaveta Gorodetska

|Apr 11, 2019
BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype.

Ielizaveta Gorodetska, Vasyl Lukiyanchuk, Claudia Peitzsch

Pageof 2